You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
遠大醫藥(00512.HK)擬投資信銀遠大醫療投資基金5000萬美元
格隆匯 06-22 17:57

格隆匯6月22日丨遠大醫藥(00512.HK)公告,於2020年6月22日,宏力(一間公司全資擁有附屬公司,為基金的有限合夥人)與普通合夥人信銀遠大醫療基金管理有限公司訂立了認購協議,內容為有關集團對一個基金(信銀遠大醫療投資基金有限合夥)進行投資。根據宏力訂立認購協議,集團擬作出的資本承諾為美金5000萬元。基金計劃募集共美金2億元。

信銀投資於一九八四年在香港註冊成立,是中信銀行股份有限公司的附屬公司,其中中信銀行持股99.05%,中信銀行(國際)有限公司持股0.95%。經營範圍主要包括貸款業務(持有香港放債人牌照)及投資業務(主要包括債券投資、基金投資、股票投資和長期股權投資等),並通過其附屬公司開展投行業務及股權投資基金管理業務等。

集團主要從事研發、製造及銷售醫藥製劑、醫療器械、特色原料藥及生物健康產品。目前集團正在加速投資創新性技術和產品,在全球範圍內尋找優質研發項目擴充集團的研發管綫和提高集團的研發實力,大力向創新和國際化進行轉型。基金的投資範圍和領域與集團發展目標高度契合,即主要包括投資(但不限於)世界領先的醫藥公司及醫藥器械生產商(主要集中於生物製藥、心血管、眼科、腫瘤治療等領域)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account